Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$48.37 - $66.5 $12 Million - $16.5 Million
-248,100 Reduced 89.57%
28,900 $1.47 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $12 Million - $16.5 Million
-248,100 Reduced 89.57%
28,900 $1.47 Million
Q2 2022

Sep 21, 2023

BUY
$57.25 - $86.63 $15.5 Million - $23.4 Million
270,100 Added 3914.49%
277,000 $17.3 Million
Q2 2022

Aug 15, 2022

BUY
$57.25 - $86.63 $15.5 Million - $23.4 Million
270,100 Added 3914.49%
277,000 $17.3 Million
Q1 2022

Sep 21, 2023

BUY
$71.02 - $86.99 $312,488 - $382,756
4,400 Added 176.0%
6,900 $564,000
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $312,488 - $382,756
4,400 Added 176.0%
6,900 $565,000
Q4 2021

Sep 21, 2023

SELL
$76.72 - $92.68 $3.64 Million - $4.4 Million
-47,500 Reduced 95.0%
2,500 $218,000
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $191,800 - $231,700
2,500 New
2,500 $219,000
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $3.67 Million - $4.35 Million
-50,000 Closed
0 $0
Q4 2020

Sep 21, 2023

BUY
$46.01 - $68.74 $970,811 - $1.45 Million
21,100 Added 73.01%
50,000 $3.31 Million
Q4 2020

Feb 16, 2021

BUY
$46.01 - $68.74 $2.3 Million - $3.44 Million
50,000 New
50,000 $3.31 Million
Q1 2019

May 15, 2019

SELL
$86.15 - $100.49 $2.39 Million - $2.78 Million
-27,700 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $3.66 Million - $5.46 Million
-43,500 Reduced 61.1%
27,700 $2.53 Million
Q3 2018

Nov 14, 2018

BUY
$101.02 - $130.95 $1.59 Million - $2.06 Million
15,700 Added 28.29%
71,200 $8.83 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $4.54 Million - $5.85 Million
55,500 New
55,500 $5.54 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.